Finance

Lists
Why is XBRANE down 3,86%?
Dive Deeper
XBRANE:STO
Xbrane Biopharma AB
11,20 SEK
-3,86%
(-0,45) 1D
15 ოქტ, 17:29:47 GMT+2  ·   SEK
All symbols
SymbolPriceChange% Change
Generating top insights for XBRANE...
Open
11,65 SEK
High
11,65 SEK
Low
11,05 SEK
Mkt. cap
230,78 მლნ.
Avg. vol.
49,04 ათ.
Volume
0,00
52-wk high
32,65 SEK
52-wk low
5,42 SEK
EPS
-3,64 SEK
Shares outstanding
20,61 მლნ.
No. of employees
29
Open
11,65 SEK
High
11,65 SEK
Low
11,05 SEK
Mkt. cap
230,78 მლნ.
Avg. vol.
49,04 ათ.
Volume
0,00
52-wk high
32,65 SEK
52-wk low
5,42 SEK
EPS
-3,64 SEK
Shares outstanding
20,61 მლნ.
No. of employees
29
News stories
From web sources and news partners
TradingView
TradingView
·
2 დღის წინ
Xbrane Biopharma: Xdivane pivotal study fully recruited
About Xbrane Biopharma AB
CEOმარტინ ამარკ
Employees29
Founded2008
Headquarters-
Sector-
Websitexbrane.com
Previous reportsAll values in SEK
Loading Previous Earnings...
Revenue
Net income
All values in SEK
სექ. 2025
დეკ. 2025
მარ. 2026
ივნ. 2026
Revenue
10,12 მლნ.
9,09 მლნ.
17,34 მლნ.
46,75 მლნ.
Cost of goods sold
15,10 მლნ.
7,41 მლნ.
10,51 მლნ.
38,67 მლნ.
Cost of revenue
15,10 მლნ.
7,41 მლნ.
10,51 მლნ.
38,67 მლნ.
Research and development expenses
9,84 მლნ.
58,87 მლნ.
9,95 მლნ.
10,10 მლნ.
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
7,95 მლნ.
6,58 მლნ.
7,57 მლნ.
6,99 მლნ.
Operating expense
19,67 მლნ.
23,26 მლნ.
15,86 მლნ.
10,88 მლნ.
Total operating expenses
34,78 მლნ.
30,66 მლნ.
26,37 მლნ.
49,55 მლნ.
Operating income
-24,66 მლნ.
-21,58 მლნ.
-9,03 მლნ.
-2,80 მლნ.
Other non operating income
-1,00 ათ.
-4,36 მლნ.
-
1,00 ათ.
EBT including unusual items
-23,73 მლნ.
-26,20 მლნ.
-12,70 მლნ.
-11,28 მლნ.
EBT excluding unusual items
-23,73 მლნ.
-26,20 მლნ.
-12,70 მლნ.
-5,58 მლნ.
Income tax expense
6,00 ათ.
-
89,00 ათ.
-
Effective tax rate
-0,03%
-
-0,70%
-
Other operating expenses
1,88 მლნ.
-42,19 მლნ.
-1,66 მლნ.
-6,21 მლნ.
Net income
-24,03 მლნ.
-26,48 მლნ.
-13,07 მლნ.
-11,42 მლნ.
Net profit margin
-237,47%
-291,41%
-75,40%
-24,42%
Earnings per share
-1,17
-1,27
-
-
Interest and investment income
-
2,82 მლნ.
-
-
Interest expense
-196,00 ათ.
-
-2,19 მლნ.
-2,28 მლნ.
Net interest expenses
-196,00 ათ.
2,82 მლნ.
-2,19 მლნ.
-2,28 მლნ.
Depreciation and amortization charges
-
-
-
-
EBITDA
-21,87 მლნ.
-16,01 მლნ.
-6,28 მლნ.
-67,00 ათ.
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google აპები